Savers Value Village GC executes options, sells shares under 10b5-1 plan
Rhea-AI Filing Summary
Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), reported transactions dated 09/11/2025 under a 10b5-1 plan adopted March 10, 2025. He exercised 1,333 stock options with an exercise price of $1.41 per share and simultaneously sold 1,333 common shares at a weighted average price of $13.0261 (execution prices ranged from $12.98 to $13.10). After these transactions, the reporting person holds 398,123 shares of common stock. The filing notes that the exercised options were part of a 2019 Management Incentive Plan, fully vested as of March 28, 2024, and that the sold shares were executed pursuant to the 10b5-1 plan.
Positive
- Sale executed under a 10b5-1 plan, indicating a prearranged, rule-compliant disposition
- Options were fully vested as of March 28, 2024, enabling orderly exercise
- Reporting person retains 398,123 shares, maintaining significant ongoing ownership
Negative
- Insider sold 1,333 shares, which may be viewed as a liquidity action by the officer
Insights
TL;DR: Routine option exercise and preplanned sale; modest absolute size relative to total holdings.
The filing documents a synchronized exercise of options and sale of the resulting 1,333 shares under an established 10b5-1 plan, generating proceeds at a weighted average price of $13.0261 while the exercise cost was $1.41 per share. This is a common liquidity event for insiders with fully vested incentives and does not, by itself, change control or materially alter share count. The reporting person continues to beneficially own 398,123 shares, which provides ongoing alignment with shareholders.
TL;DR: Transaction follows a preapproved trading plan and shows compliance with disclosure norms.
The sale was executed pursuant to a 10b5-1 trading plan adopted March 10, 2025, which indicates a prearranged program intended to provide an affirmative defense under Rule 10b5-1. The filing discloses vesting details for the options (fully vested March 28, 2024) and specifies the provenance of option grants under the 2019 Management Incentive Plan. Signature and explanatory notes meet standard Form 4 disclosure requirements.